Document is current
Any future updates will be listed below
-
Authors
,
Sharrack, Basil
Saccardi, Riccardo
Alexander, Tobias
Badoglio, Manuela https://orcid.org/0000-0003-3226-2024
Burman, Joachim https://orcid.org/0000-0002-7045-1806
Farge, Dominique https://orcid.org/0000-0002-4041-1352
Greco, Raffaella
Jessop, Helen
Kazmi, Majid
Kirgizov, Kirill
Labopin, Myriam
Mancardi, Gianluigi
Martin, Roland https://orcid.org/0000-0002-0982-1329
Moore, John
Muraro, Paolo A. https://orcid.org/0000-0002-3822-1218
Rovira, Montserrat
Sormani, Maria Pia
Snowden, John A. https://orcid.org/0000-0001-6819-3476
- License Information
-
More Information
Article History
Received: 11 August 2019
Accepted: 17 August 2019
First Online: 26 September 2019
Compliance with ethical standards
:
: JAS declares speaker fees at educational events supported by Sanofi, Janssen, Jazz, Mallinckrodt and Gilead, is a member of a trial IDMC for Kiadis Pharma and Chairs NHS England Clinical Reference Group (CRG) for Blood and Marrow Transplantation. RM has received personal remuneration for advisory functions and presentations by Merck, Teva, Sanofi, Novartis, Roche, Biogen, Cell Protect and Neuway Pharma. He is a co-founder and co-owner of Cellerys. PAM reports personal fees and non-financial support from Bayer, Biogen, Merck and Novartis, unrelated to the manuscript. PAM, BS and JS are grateful for support from the UK NIHR EME and Biomedical Research Centre funding schemes. The other authors declare no competing interests.
